223 related articles for article (PubMed ID: 36242022)
1. Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Colarusso A; Lauro C; Calvanese M; Parrilli E; Tutino ML
Microb Cell Fact; 2022 Oct; 21(1):211. PubMed ID: 36242022
[TBL] [Abstract][Full Text] [Related]
2. Soluble Recombinant Protein Production in Pseudoalteromonas haloplanktis TAC125: The Case Study of the Full-Length Human CDKL5 Protein.
Calvanese M; Colarusso A; Lauro C; Parrilli E; Tutino ML
Methods Mol Biol; 2022; 2406():219-232. PubMed ID: 35089560
[TBL] [Abstract][Full Text] [Related]
3. Development of high-copy number plasmids in Pseudoalteromonas haloplanktis TAC125.
Calvanese M; Balestra C; Colarusso A; Lauro C; Riccardi C; Fondi M; Parrilli E; Tutino ML
Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2469-2481. PubMed ID: 36912903
[TBL] [Abstract][Full Text] [Related]
4. A novel synthetic medium and expression system for subzero growth and recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
Sannino F; Giuliani M; Salvatore U; Apuzzo GA; de Pascale D; Fani R; Fondi M; Marino G; Tutino ML; Parrilli E
Appl Microbiol Biotechnol; 2017 Jan; 101(2):725-734. PubMed ID: 27796433
[TBL] [Abstract][Full Text] [Related]
5. Genome-scale metabolic reconstruction and constraint-based modelling of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Fondi M; Maida I; Perrin E; Mellera A; Mocali S; Parrilli E; Tutino ML; Liò P; Fani R
Environ Microbiol; 2015 Mar; 17(3):751-66. PubMed ID: 24889559
[TBL] [Abstract][Full Text] [Related]
6. Soluble recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
Giuliani M; Parrilli E; Sannino F; Apuzzo G; Marino G; Tutino ML
Methods Mol Biol; 2015; 1258():243-57. PubMed ID: 25447868
[TBL] [Abstract][Full Text] [Related]
7. Recombinant production of a single-chain antibody fragment in Pseudoalteromonas haloplanktis TAC125.
Giuliani M; Parrilli E; Sannino F; Apuzzo GA; Marino G; Tutino ML
Appl Microbiol Biotechnol; 2014 Jun; 98(11):4887-95. PubMed ID: 24535258
[TBL] [Abstract][Full Text] [Related]
8. Life in the cold: a proteomic study of cold-repressed proteins in the antarctic bacterium pseudoalteromonas haloplanktis TAC125.
Piette F; D'Amico S; Mazzucchelli G; Danchin A; Leprince P; Feller G
Appl Environ Microbiol; 2011 Jun; 77(11):3881-3. PubMed ID: 21478318
[TBL] [Abstract][Full Text] [Related]
9. The cold-active Lip1 lipase from the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 is a member of a new bacterial lipolytic enzyme family.
de Pascale D; Cusano AM; Autore F; Parrilli E; di Prisco G; Marino G; Tutino ML
Extremophiles; 2008 May; 12(3):311-23. PubMed ID: 18437283
[TBL] [Abstract][Full Text] [Related]
10. Development of an improved Pseudoalteromonas haloplanktis TAC125 strain for recombinant protein secretion at low temperature.
Parrilli E; De Vizio D; Cirulli C; Tutino ML
Microb Cell Fact; 2008 Feb; 7():2. PubMed ID: 18257924
[TBL] [Abstract][Full Text] [Related]
11. Regulated recombinant protein production in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Rippa V; Papa R; Giuliani M; Pezzella C; Parrilli E; Tutino ML; Marino G; Duilio A
Methods Mol Biol; 2012; 824():203-18. PubMed ID: 22160900
[TBL] [Abstract][Full Text] [Related]
12. Recombinant protein production in Antarctic Gram-negative bacteria.
Duilio A; Tutino ML; Marino G
Methods Mol Biol; 2004; 267():225-37. PubMed ID: 15269427
[TBL] [Abstract][Full Text] [Related]
13. Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis.
Vigentini I; Merico A; Tutino ML; Compagno C; Marino G
J Biotechnol; 2006 Dec; 127(1):141-50. PubMed ID: 16859797
[TBL] [Abstract][Full Text] [Related]
14. Identification of the transcription factor responsible for L-malate-dependent regulation in the marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Papa R; Rippa V; Duilio A
FEMS Microbiol Lett; 2009 Jun; 295(2):177-86. PubMed ID: 19646180
[TBL] [Abstract][Full Text] [Related]
15. Conditional gene silencing in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Lauro C; Colarusso A; Calvanese M; Parrilli E; Tutino ML
Res Microbiol; 2022; 173(4-5):103939. PubMed ID: 35307545
[TBL] [Abstract][Full Text] [Related]
16. Engineered marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125: a promising micro-organism for the bioremediation of aromatic compounds.
Papa R; Parrilli E; Sannia G
J Appl Microbiol; 2009 Jan; 106(1):49-56. PubMed ID: 19120609
[TBL] [Abstract][Full Text] [Related]
17. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
[TBL] [Abstract][Full Text] [Related]
18. Recombinant expression of Toluene o-Xylene Monooxygenase (ToMO) from Pseudomonas stutzeri OX1 in the marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Siani L; Papa R; Di Donato A; Sannia G
J Biotechnol; 2006 Nov; 126(3):334-41. PubMed ID: 16730836
[TBL] [Abstract][Full Text] [Related]
19. Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.
Unzueta U; Vázquez F; Accardi G; Mendoza R; Toledo-Rubio V; Giuliani M; Sannino F; Parrilli E; Abasolo I; Schwartz S; Tutino ML; Villaverde A; Corchero JL; Ferrer-Miralles N
Appl Microbiol Biotechnol; 2015 Jul; 99(14):5863-74. PubMed ID: 25616525
[TBL] [Abstract][Full Text] [Related]
20. Modelling hCDKL5 Heterologous Expression in Bacteria.
Fondi M; Gonzi S; Dziurzynski M; Turano P; Ghini V; Calvanese M; Colarusso A; Lauro C; Parrilli E; Tutino ML
Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
